Associated Papers
Associations between the IASLC/ATS/ERS lung adenocarcinoma classification and EGFR and KRAS mutations.
Clay TD et al.
Pathology, 2016
EGFR gene copy number alterations are not a useful screening tool for predicting EGFR mutation status in lung adenocarcinoma.
Russell PA et al.
Pathology, 2014
Select a paper to view details